Overview

Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
Use of linezolid in patients with methicillin-resistant Staphylococcus aureus infections in Japan
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Linezolid